| First Author | Strubberg AM | Year | 2018 |
| Journal | Stem Cell Reports | Volume | 11 |
| Issue | 2 | Pages | 410-424 |
| PubMed ID | 30017821 | Mgi Jnum | J:315631 |
| Mgi Id | MGI:6829437 | Doi | 10.1016/j.stemcr.2018.06.009 |
| Citation | Strubberg AM, et al. (2018) The Zinc Finger Transcription Factor PLAGL2 Enhances Stem Cell Fate and Activates Expression of ASCL2 in Intestinal Epithelial Cells. Stem Cell Reports 11(2):410-424 |
| abstractText | Intestinal epithelial stem cell (IESC) fate is promoted by two major transcriptional regulators, the TCF4/beta-catenin complex and ASCL2, which drive expression of IESC-specific factors, including Lgr5, Ephb2, and Rnf43. Canonical Wnt signaling via TCF4/beta-catenin directly transactivates Ascl2, which in turn auto-regulates its own expression. Conversely, Let-7 microRNAs antagonize the IESC lineage by repressing specific mRNA targets. Here, we identify the zinc finger transcription factor PLAGL2 as a Let-7 target that regulates IESC fate. PLAGL2 drives an IESC expression signature, activates Wnt gene expression, and enhances a TCF/LEF reporter in intestinal organoids. In parallel, via cell-autonomous mechanisms, PLAGL2 is required for lineage clonal expansion and directly enhances expression of ASCL2. PLAGL2 also supports enteroid growth and survival in the context of Wnt ligand depletion. PLAGL2 expression is strongly associated with an IESC signature in colorectal cancer and may be responsible for contributing to the aberrant activation of an immature phenotype. |
